Claire Seedhouse, Rowena Bainton, Michael Lewis, Alexander Harding, Nigel Russell, and Emma Das-Gupta
|
|
- Kevin Griffin
- 5 years ago
- Views:
Transcription
1 NEOPLASIA The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia Claire Seedhouse, Rowena Bainton, Michael Lewis, Alexander Harding, Nigel Russell, and Emma Das-Gupta Polymorphisms in several DNA repair genes have been described. These polymorphisms may affect DNA repair capacity and modulate cancer susceptibility by means of gene-environment interactions. We investigated DNA repair capacity and its association with acute myeloblastic leukemia (AML). We studied polymorphisms in 3 DNA repair genes: XRCC1, XRCC3, and XPD. We also assessed the incidence of a functional polymorphism in the NQO1 gene, which is involved in protection of cells from oxidative damage. We genotyped the polymorphisms by using polymerase chain reaction Introduction restriction fragment-length polymorphism analysis in 134 patients with de novo AML, 34 with therapy-related AML (t-aml), and 178 controls. The distributions of the XRCC3 Thr241Met and NQO1 Pro187Ser genotypes were not significantly different in patients and controls. However, the distribution of the XRCC1 Arg399Gln genotypes was significantly different when comparing the t-aml and control groups ( 2, P.03). The presence of at least one XRCC1 399Gln allele indicated a protective effect for the allele in controls compared with patients with t-aml (odds ratio 0.44; 95% confidence interval, ). We found no interactions between the XRCC1 or XRCC3 and NQO1 genotypes. We also found no differences in the distribution of the XPD Lys751Gln or XRCC1 Arg194Trp genotypes. Our data provide evidence of a protective effect against AML in individuals with at least one copy of the variant XRCC1 399Gln allele compared with those homozygous for the common allele. (Blood. 2002;100: ) 2002 by The American Society of Hematology Acute myeloblastic leukemia (AML) is a clonal hemopoietic disorder that is frequently associated with genetic instability characterized by a diversity of chromosomal and molecular changes. Most cases of AML arise de novo, with no known exposure to leukemogenic substances. However, approximately 10% to 20% of all cases of AML arise after therapy, most often chemotherapy, used to treat other malignant diseases (therapy-related AML [t-aml] 1 ). Many genes encode proteins that function to protect cells against genetic instability by means of many mechanisms, including DNA repair pathways and protection against oxidative stress. DNA repair pathways play a vital role in maintaining genetic integrity, and it is becoming clear that defects in repair pathways are connected to many different types of diseases, including leukemia and cancer. It is now thought that an individual s DNA repair capacity is genetically determined and is the result of combinations of multiple genes that may display subtle differences in their activity (see Mohrenweiser and Jones 2 for review). Inactivating mutations in DNA repair genes are rare, resulting in embryonic death or serious genetic diseases and reflecting the importance of the gene products; however, polymorphisms have been identified in several DNA repair genes. 3 Many of these polymorphisms result in amino acid substitutions and hence may alter wild-type (WT) protein function and affect cellular ability to repair endogenous and exogenous DNA damage, thereby contributing to disease susceptibility. XRCC1, XRCC3, and XPD are polymorphic genes belonging to 3 of the major DNA repair pathways. XRCC1 is involved in base excision repair (BER) and the repair of single-strand breaks. The XRCC1 gene product plays an important role in the pathway by acting as a scaffold for other DNA repair proteins, such as DNA polymerase 4 and DNA ligase III. 5 The protein also has a BRCA1 C-terminus (BRCT) domain, which is characteristic of proteins involved in the recognition of and response to DNA damage. XRCC1 interacts with poly (ADP-ribose) polymerase (PARP) by means of the BRCT domain to enable the recognition and subsequent repair of single-strand breaks. 6,7 DNA damage caused by a variety of internal and external factors, including ionizing radiation, alkylating agents, and oxidation, requires repair by the BER pathway. Several variants of XRCC1 have been described, including one affecting codon 399 in exon 10 that results in an arginine (Arg) to methionine (Met) substitution 3 and one affecting codon 194 in exon 6 that results in an Arg to tryptophan (Trp) substitution. Both codon 194 and codon 399 are conserved across species. Codon 194 resides in a linker region connecting the domains that interact with PARP and DNA polymerase, whereas codon 399 resides in the functionally important PARP-binding domain. 8 Chinese hamster ovary cell lines with nonconservative amino acid substitutions in the PARP-binding domain were found to have a decreased ability to repair DNA damage. 9 From the Division of Haematology, School of Clinical Laboratory Sciences, University of Nottingham, and Nottingham City Hospital, Nottingham, United Kingdom. Submitted April 16, 2002; accepted July 1, Prepublished online as Blood First Edition Paper, July 18, 2002; DOI /blood Sponsored partly by a grant from the Leukaemia Research Fund, United Kingdom. Reprints: Claire Seedhouse, Department of Academic Haematology, Clinical Sciences Building, Nottingham City Hospital, Nottingham, NG5 1PB, United Kingdom; claire.seedhouse@nottingham.ac.uk. The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked advertisement in accordance with 18 U.S.C. section by The American Society of Hematology BLOOD, 15 NOVEMBER 2002 VOLUME 100, NUMBER
2 3762 SEEDHOUSE et al BLOOD, 15 NOVEMBER 2002 VOLUME 100, NUMBER 10 The XRCC3 protein functions in the homologous DNA doublestrand break (DSB) repair pathway and directly interacts with and stabilizes Rad51, 10 one of the key components of the pathway. The homologous DNA DSB repair pathway uses the second, intact copy of a chromosome as a template to copy the information lost at the DSB site on the first chromosome, resulting in a high-fidelity process that has a vital role in preventing chromosomal aberrations. The threonine (Thr) to Met polymorphism at codon 241 of XRCC3 is a nonconservative change. Little is known about the functional consequence of this amino acid change, although positive associations between the variant allele and cancer have been observed in various investigations, including studies of bladder cancer 11 and melanoma skin cancer. 12 The XPD protein, a 5 to 3 DNA helicase involved in the nucleotide excision repair pathway, functions to remove bulky damage adducts from DNA. The XPD lysine (Lys) 751 glutamine (Gln) polymorphism does not reside in a known functional domain of XPD and was initially thought to be unlikely to result in an altered DNA repair capacity. 3,13 However, additional studies produced contrasting results, linking the XPD 751Gln variant allele to both reduced 14 and elevated 15 nucleotide excision repair capacity. Thus, more work is warranted to establish whether this polymorphism is clinically relevant. Nicotinamide adenine dinucleotide phosphate:quinone oxidoreductase 1 (NQO1) functions to protect cells from oxidative stress by detoxifying several compounds. The enzyme reduces reactive quinones to the less reactive hydroquinones and so prevents accumulation of reactive oxygen species that may then go on to damage DNA. A polymorphism has been identified in NQO1 at codon This polymorphism converts a proline (Pro) to a serine (Ser) residue and has been shown to result in inactivation of NQO1. 17 The incidence of this polymorphism was found to be significantly increased both in patients with de novo AML 18 and in those with t-aml, particularly those with chromosome 5/7 abnormalities. 19 In the current study, we investigated the genotype distributions of the XRCC1 Arg399Gln, XRCC3 Thr241Met, and NQO1 Pro187Ser polymorphisms in patients with AML, particularly those with t-aml, and in controls. We also studied the distribution of the XRCC1-194 and XPD-751 genotypes. In addition, because a malignant phenotype is likely to result from the accumulation of many minor genotypes, we assessed whether there was an association between DNA repair gene polymorphisms (XRCC1 and XRCC3) and a polymorphism in a protein involved with minimizing the effects of oxidative stress (NQO1). Materials and methods Study subjects Blood or bone marrow samples were obtained at the diagnosis of AML, after informed consent to participate was given according to the Declaration of Helsinki, from 168 white patients, including 34 with t-aml, presenting to the Haematology Department of Nottingham City Hospital. The diagnosis of AML was made by using the French-American-British criteria after conventional cytochemical and surface-marker analysis. The median age among patients with de novo AML was 63 years (range, years); that among those with t-aml was 61.5 years (range, years). Control peripheral blood samples were obtained from an equivalent number (n 178; median age, 51.5 years; range, years) of whites with no known malignant diseases who resided in the same geographic community. Samples were not matched for sex; however, previous investigations consistently found no significant difference between male and female subjects in the distribution of the genotypes investigated in this study. 14,20 Genomic DNA was extracted from cells by using QIAamp blood DNA isolation kits (Qiagen, Crawley, United Kingdom) according to the manufacturer s protocol. Polymerase chain reaction (PCR) restriction fragment-length polymorphism (RFLP) genotyping analysis PCR followed by enzymatic digestion of the PCR products was used for genotyping the 3 polymorphisms. Approximately 50 ng genomic DNA was used as template in each of the PCR amplifications. The 50- L reaction also consisted of 150 M of each deoxynucleoside triphosphate (Amersham Biosciences, Little Chalfont, United Kingdom), 1 M of each primer, 1.5 to 2.0 mm/l magnesium chloride (MgCl 2 ), and 2 U Amplitaq Gold (PE Applied Biosystems, Warrington, United Kingdom) in the manufacturer s buffer. After an initial heat-activation step at 95 C for 10 minutes, amplification was performed in a PTC-100 programmable thermal controller (MJ Research, Watertown, MA). For XRCC1 Arg399Gln, XRCC1 Arg194Gln, XPD Gln751Lys, and XRCC3 Thr241Met, we used denaturation at 95 C for 1 minute, annealing at 60 C for 1 minute, and extension at 72 C for 1 minute for a total of 30 cycles ending with a final extension at 72 C for 10 minutes. For NQO1 Pro187Ser, we used denaturation at 94 C for 50 seconds, 52 C for 50 seconds, and 72 C for 30 seconds for a total of 35 cycles, followed by a final extension step at 72 C for 10 minutes. PCR products were purified by using a QIAquick PCR purification kit (Qiagen) before digestion and/or sequencing. The XRCC1 Arg399Gln polymorphism was amplified in a 616-bp fragment by using the following primers: xrcc1-399f 5 -TTGTGCTT- TCTCTGTGTCCA-3 and xrcc1-399r 5 -TCCTCCAGCCTTTACTGATA with 2 mm/l MgCl 2. The PCR product was digested with 10 U MspI (Helena Biosciences, Sunderland, United Kingdom) in the manufacturer s buffer at 37 C overnight. The recognition site for the MspI restriction endonuclease is present only in the Arg (WT) allele; hence, digestion of the Arg allele results in products of 376 bp and 240 bp, whereas the Gln allele remains undigested. A segment of the XRCC1 gene containing the Arg194Trp polymorphism was amplified by using the primer pairs xrcc1-194f 5 -GGTAAGCTGTAC- CTGTCACTC-3 and xrcc1-194r 5 -GACCCAGGAATCTGAGCC-3 with 1.5 mm/l MgCl 2. The PCR products were digested at 37 C overnight with 10 U MspI. The PCR product contains an internal MspI site, and products with the 194Arg genotype contain an additional MspI site, resulting in 20-, 117-, and 167-bp products. The 194Trp allele is digested only at the internal MspI site, resulting in 137- and 167-bp products. XRCC3 Thr241Met was amplified in a 415-bp product by using the primers xrcc3-241f 5 -GGTCGAGTGACAGTCCAAAC-3 and xrcc3-241r 5 -CTACCCGCAGGAGCCGGAGG-3 3 with 2 mm/l MgCl 2. The PCR products were digested at 37 C overnight with 10 U NlaIII (New England Biolabs, Hitchin, United Kingdom) in 1 buffer supplied with the enzyme and supplemented with 100 ng/ L bovine serum albumin. All XRCC3 PCR products contain an internal NlaIII site, and the presence of the Met polymorphism also generates an additional NlaIII site, resulting in 104-, 141-, and 170-bp products for the polymorphic allele and 141- and 274-bp products for the WT Thr allele. The XPD Lys751Gln polymorphism was amplified in a 344-bp fragment by using the following primers: xpd-751f 5 -TCAAACATCCT- GTCCCTACT-3 and xpd-751r 5 -CTGCCGATTAAAGGCTGTGGA-3 3 with 2 mm/l MgCl 2. The PCR product was digested with 10 U PstI (Helena Biosciences) at 37 C overnight. All PCR products contain an internal PstI site, resulting in 110- and 234-bp products in the 751Lys allele. In addition, an extra PstI site is present in the Gln allele, resulting in 63-, 110-, and 171-bp products. The NQO1 Pro187Ser polymorphism was amplified in a 304-bp fragment by using the primers nqo1f 5 -AAGCCCAGACCAACTTCT-3 and nqo1r 5 -TCTCCTCATCCTGTACCTCT-3 15 with 1.5 mm/l MgCl 2. The PCR products were digested overnight at 37 C with 10 U HinfI (New England Biolabs) in the manufacturer s buffer. All PCR products contain an internal HinfI site, and the Ser polymorphism also introduces an additional HinfI site, resulting in 33-, 120-, and 151-bp digested fragments, whereas the WT allele results in 33- and 271-bp products.
3 BLOOD, 15 NOVEMBER 2002 VOLUME 100, NUMBER 10 POLYMORPHISMS IN AML 3763 The digested products were resolved on 3% agarose gels (Helena Biosciences), stained with ethidium bromide and analyzed under UV light. Two reviewers independently scored all genotypes, and samples that could not be scored were sequenced. Sequencing was also carried out on a 10% random sample population of control and AML PCR products. Sequencing reactions Sequencing reactions were set up with approximately 200 ng purified PCR product and 10 mm primer by using a Thermo Sequenase II dye terminator cycle sequencing premix kit according to the manufacturer s instructions (Amersham Biosciences). The primers used for sequencing were the same as those used for the PCR amplifications. The reactions were electrophoresed by using an ABI 377 automated DNA sequencer (PE Applied Biosystems, Foster City, CA) as recommended by the manufacturer. Statistical analysis The observed genotype frequencies of the 3 polymorphisms in the control cohorts were compared with those calculated by using the Hardy-Weinberg equilibrium (p2 q2 2pq 1; where p is the variant allele frequency). The distribution of genotypes in AML populations compared with the control population was assessed for significance by 2 testing, and odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by logistic regression analysis and adjusted for the effect of age. P values of less than or equal to.05 were considered to represent significance. All analyses used the statistical package SPSS for Windows (version 9; SPSS, Chicago, IL). Results XRCC1 Arg399Gln, XRCC3 Thr241Met, and NQO1 Pro187Ser polymorphisms We examined the frequency of 3 polymorphisms in 134 patients with de novo AML (median age, 63 years) and 178 controls (median age, 51.5 years). We also analyzed a subgroup of 34 patients with t-aml (median age, 61.5 years). Because of an inadequate amount of DNA in some cases, several samples did not generate complete information for all 3 polymorphisms. Among the controls, the variant allele frequencies were 0.48 for XRCC1 399Gln, 0.30 for XRCC3 241Met, and 0.22 for NQO1 187Ser. All genotype frequencies in the control population were consistent with those expected from the Hardy-Weinberg equilibrium (XRCC1 Arg399Gln, and P.38; XRCC3 Thr241Met, and P.54; and NQO1 Pro187Ser, and P.63). The distributions of the frequencies of the polymorphisms in AML cases and controls are shown in Table 1. The results for the XRCC1 Arg399Gln polymorphism showed that the proportion of AML and t-aml patients homozygous for the WT Arg allele was higher than in the control group, with the difference in the distribution of genotypes reaching statistical significance in the t-aml group (P.03 on 2 testing). Neither the XRCC3-241 nor the NQO1 genotype distributions showed any differences in either the de novo AML or t-aml group compared with the control group. The adjusted ORs for the individual genotypes are shown in Table 2. The XRCC1 399 homozygous variant genotype is a protective factor in both the de novo AML and t-aml patient groups. When the presence of at least one Gln allele is considered, it becomes apparent that the variant allele is significantly protective against the development of t-aml (OR, 0.46; 95% CI, ). XRCC1 Arg194Trp and XPD Lys751Gln polymorphisms We also studied 2 additional polymorphisms, XRCC1 Arg194Trp and XPD Lys751Gln, in a smaller cohort of patients and controls. Table 1. Frequency of polymorphisms in AML and control populations Polymorphism Controls Patients with AML Patients with t-aml XRCC Arg/Arg 55 (30.9) 52 (39.1) 18 (52.9) Arg/Gln 76 (42.7) 57 (42.9) 12 (35.3) Gln/Gln 47 (26.4) 24 (18.0) 4 (11.8) P on 2 * Arg/Arg 55 (30.9) 52 (39.1) 18 (52.9) Arg/Gln Gln/Gln 123 (69.1) 81 (60.9) 16 (47.1) P on 2 * XRCC Thr/Thr 92 (52.6) 53 (43.1) 12 (38.7) Thr/Met 64 (36.6) 53 (43.1) 12 (38.7) Met/Met 19 (10.9) 17 (13.8) 7 (22.6) P on 2 * Thr/Thr 92 (52.6) 53 (43.1) 12 (38.7) Thr/Met Met/Met 83 (47.4) 70 (56.9) 19 (61.3) P on 2 * NQO Pro/Pro 110 (62.9) 95 (70.9) 19 (57.6) Pro/Ser 53 (30.3) 30 (22.4) 14 (42.4) Ser/Ser 12 (6.9) 9 (6.7) 0 (0) P on 2 * Pro/Pro 110 (62.9) 95 (70.9) 19 (57.6) Pro/Ser Ser/Ser 65 (37.1) 39 (29.1) 14 (42.4) P on 2 * XRCC Arg/Arg 78 (89.7) 100 (89.3) 12 (85.7) Arg/Trp 7 (8.0) 12 (10.7) 2 (14.3) Trp/Trp 2 (2.3) 0 (0) 0 (0) P on 2 * Arg/Arg 78 (89.7) 100 (89.3) 12 (85.7) Arg/Trp Trp/Trp 9 (10.3) 12 (10.7) 2 (14.3) P on 2 * XPD Lys/Lys 30 (41.1) 40 (37.4) 4 (26.7) Lys/Gln 32 (43.8) 51 (47.7) 8 (53.3) Gln/Gln 11 (15.1) 16 (15.0) 3 (20) P on 2 * Lys/Lys 30 (41.1) 40 (37.4) 4 (26.7) Lys/Gln Gln/Gln 43 (58.9) 67 (62.6) 11 (73.3) P on 2 * Values are numbers (%) of controls or patients unless otherwise indicated. *For comparisons between patients and controls. Among the controls, the variant allele frequencies were 0.07 for XRCC1 194Trp and 0.38 for XPD 751Gln. The genotype distributions among the control population were consistent with those expected from the Hardy-Weinberg equilibrium (XRCC1 Arg194Trp, and P.29; and XPD Lys751Gln, and P.88). The distributions of the frequencies of the polymorphisms in AML patients and controls are shown in Table 1; adjusted ORs are shown in Table 2. No significant differences were observed between the AML patient cohort and the controls. Combined analysis of polymorphisms Table 3 shows the combined analysis for either the XRCC1 Arg399Gln or XRCC3 Thr241Met genotypes with the NQO1 Pro187Ser genotype. Because of the small numbers of t-aml samples available, these were grouped with the samples from the de novo AML cases for this analysis. The DNA repair gene polymorphisms did not show an interaction with the detoxification NQO1 Pro187Ser polymorphism.
4 3764 SEEDHOUSE et al BLOOD, 15 NOVEMBER 2002 VOLUME 100, NUMBER 10 Table 2. Estimates of relative risk for AML associated with various genotypes Genotype Controls Patients with AML OR (95% CI)* P Patients with t-aml OR (95% CI)* P XRCC Arg/Arg Arg/Gln ( ) ( ).14 Gln/Gln ( ) ( ).03 Arg/Gln Gln/Gln ( ) ( ).03 XRCC Thr/Thr Thr/Met ( ) ( ).33 Met/Met ( ) ( ).08 Thr/Met Met/Met ( ) ( ).14 NQO Pro/Pro Pro/Ser ( ) ( ).22 Ser/Ser ( ).49 0 Pro/Ser Ser/Ser ( ) ( ).45 XRCC Arg/Arg Arg/Trp ( ) ( ).49 Trp/Trp Arg/Trp Trp/Trp ( ) ( ).48 XPD Lys/Lys Lys/Gln ( ) ( ).08 Gln/Gln ( ) ( ).94 Lys/Gln Gln/Gln ( ) ( ).15 *Adjusted for age. Used as the reference group. Discussion Although it has been established that mismatch repair is important in a subset of patients with AML, little is known about the role of the other DNA repair pathways in this disease. In this study, we found that a polymorphism in a DNA repair gene belonging to the BER pathway, XRCC1 Arg399Gln, is associated with a protective effect against the development of AML, particularly t-aml. Hence, patients in whom AML develops as a result of therapy for a primary malignant disease are more likely to have the WT XRCC1 399 Arg allele. It is possible that differences between the cases and controls may have contributed to the observed association, but we believe that this is unlikely. Both populations were from the same small geographical area in the United Kingdom and had the same age range. Sex has been shown not to have any influence on the XRCC1 Arg399Gln genotype, 20 and although race was previously found to be an important factor in the distribution of the XRCC1 Arg399Gln genotype, 25,26 all our patients and controls were white. We did not find any differences between the distributions of the XRCC3 Thr241Met and NQO1 Pro187Ser genotypes. Others have observed a significant increase in the incidence of the variant NQO1 allele in patients with AML, particularly those with chromosome 5/7 abnormalities. 19 This association was not evident in our AML groups, although the number of patients with chromosome 5/7 abnormalities in our cohort was small and that may have accounted for the difference from previous studies. We were able to obtain cytogenetic information for approximately 100 of our patients, and only 10 of them had chromosome 5/7 abnormalities. We combined the de novo AML and t-aml groups to examine possible associations between either the XRCC1 Arg399Gln or XRCC3 Thr241Met genotypes and the NQO1 Pro187Ser genotypes. No significant association was observed, Table 3. Combined logistic regression analysis of the association between DNA repair and NQO1 genotype and the risk of AML Repair genotype Detoxification genotype Controls Patients with AML* OR (95% CI) P XRCC1-399 NQO1-187 WT WT V WT ( ).13 WT V ( ).46 V V ( ).14 XRCC3-241 NQO1-187 WT WT V WT ( ).19 WT V ( ).46 V V ( ).51 WT indicates wild-type genotype; V, presence of a variant allele (either heterozygous or homozygous). *The AML group in this analysis included both de novo AML and t-aml cases. Adjusted for age. Used as the reference group.
5 BLOOD, 15 NOVEMBER 2002 VOLUME 100, NUMBER 10 POLYMORPHISMS IN AML 3765 suggesting that the phenotypes resulting from these proteins do not interact to increase the risk of AML. However, our number of t-aml samples was too small to allow us to conduct combined logistic regression analysis of this group alone. We also performed PCR-RFLP analysis of a smaller number of patients and controls to study the distribution of genotypes of an additional polymorphism in XRCC1 (XRCC1 Arg194Trp) and a polymorphism in XPD (XPD Lys751Gln), a gene involved in the nucleotide excision repair pathway. No significant differences were found between controls and patients with AML. Several previous studies assessed the functional relevance of polymorphisms in DNA repair genes. Lunn et al 21 measured genotoxic end points of DNA damage and showed that the XRCC1 399Gln allele was associated with increased placental aflatoxin DNA adducts and increased glycophorin A mutations in erythrocytes. They suggested that the Arg to Gln change at codon 399 may alter the phenotype of the XRCC1 protein, resulting in deficient DNA repair. In addition, Duell et al 27 measured DNA damage by using a sister chromatid exchange assay and also detected polyphenol DNA adducts. They found more damage in current smokers homozygous for the XRCC1 399Gln allele than in current smokers with the homozygous WT allele. A sister chromatid assay was also used by Abdel-Rahman and El-Zein, 28 who found that a higher level of DNA damage after treatment with a tobacco-specific nitrosamine occurred in XRCC1 399Gln homozygotes. Several polymorphism studies have observed a positive association of the XRCC1 399 Gln allele with various malignant diseases, including cancer of the head and neck, 20 breast, 25 lung, 26 and colon and rectum. 29 The researchers suggested that these results correlated with the in vitro functional data and illustrated the adverse effects of deficient DNA repair systems. However, other studies, including ours, had conflicting results. We found that the presence of the XRCC1 399Gln allele is protective against the development of t-aml. The same protective effect has been observed in studies of bladder cancer 30 and nonmelanoma skin cancer. 31 This may indicate the presence of a strong gene-environment interaction that is tumor specific. There is a fine balance between deficient and functional DNA repair systems. Although it is important for damaged DNA to be recognized and repaired, it is also vital for the cell to be able to recognize when the damage is too extensive to be repaired and to allow the apoptotic pathway to be stimulated; this prevents cells from potentially misrepairing damage and surviving with mutations. This process may be particularly important in the development of t-aml. Chemotherapy and radiotherapy both induce immense amounts of DNA damage and have the aim of achieving cell death. Even subtle changes in DNA repair capacity References are likely to be important when large external influences such as chemotherapy or radiotherapy are present. We hypothesize that when hematopoietic progenitor cells in the bone marrow are damaged by therapy, the cells with the XRCC1 399 Gln allele and resulting reduced DNA repair capacity are more likely to be driven toward apoptosis. This is contrary to what happens to cells with the WT genotype, which are more likely to repair their damage, possibly harbor mutations, and initiate clonal disease resulting in t-aml. Hence, we suggest the XRCC1 399 Gln allele is protective against the development of t-aml. A similar proposal was made by Nelson et al 31 in their large study of nonmelanoma skin cancer. Our hypothesis can be extended to the opposite situation observed in many primary malignant diseases in which the XRCC1 399Gln allele has been shown to be a risk factor. Although DNA damage caused by low-dose exogenous sources (for example, smoking and diet) is considered to be an important contributory factor in many malignant diseases, the resulting oxidative burden on the cells is significantly smaller than that following chemotherapy or radiotherapy, which can be considered to cause highdose damage. Hence, a BER pathway with a fully functional XRCC1 gene (XRCC1 399Arg) would be expected to repair the damage caused by low-dose damaging agents (smoking and diet), whereas a deficiency in the DNA repair pathway, such as an XRCC1 399Gln allele, would reduce the effectiveness of the pathway in repairing damage from low-dose sources and thus increase the risk of a primary malignant disease. Additional work is now required to determine whether polymorphisms do indeed lead to a reduced DNA repair capacity in vivo and to identify the consequences of these phenotypes in different environmental conditions. The identification of polymorphisms or mutations in many genes and the determination of their functional importance in AML will allow susceptibility-risk models to be designed for de novo and therapy-related disease. Intervention strategies and early detection approaches could then be targeted at those individuals genetically identified to be at higher risk of AML or t-aml. Acknowledgments We thank Tricia McKeever for assistance with the statistical analysis; Stephen Langabeer and the Kay Kendall Leukaemia Fund for t-aml DNA samples from the DNA/RNA banking facilities at University College Hospital, London; and the Medical Research Council (MRC) Acute Leukaemia Working Party for access to samples from patients with AML entered into MRC trials. 1. Pedersen-Bjergaard J, Andersen MK, Christiansen DH, Nerlov C. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood. 2002;99: Mohrenweiser HW, Jones IM. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat Res. 1998;400: Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58: Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE, Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase and the XRCC1 protein. EMBO J. 1996;15: Caldecott KW, McKeown CK, Tucker JD, Ljungquist S, Thompson LH. An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol Cell Biol. 1994;14: Caldecott KW, Aoufouchi S, Johnson P, Shall S. XRCC1 polypeptide interacts with DNA polymerase and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular nicksensor in vitro. Nucleic Acids Res. 1996;24: Masson M, Niedergang C, Schreiber V, Muller S, Menissier-de Murcia J, de Murcia G. XRCC1 is specifically associated with poly(adp-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol. 1998;18: Lamerdin JE, Montgomery MA, Stilwagen SA, et al. Genomic sequence comparison of the human and mouse XRCC1 DNA repair gene regions. Genomics. 1995;25: Shen MR, Zdzienicka MZ, Mohrenweiser H, Thompson LH, Thelen MP. Mutations in hamster single-strand break repair gene XRCC1 causing defective DNA repair. Nucleic Acids Res. 1998; 26: Bishop DK, Ear U, Bhattacharyya A, et al. Xrcc3 is required for assembly of Rad51 complexes in vivo. J Biol Chem. 1998;273: Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a casecontrol study. Int J Cancer. 2001;92: Winsey SL, Haldar NA, Marsh HP, et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res. 2000;60:
6 3766 SEEDHOUSE et al BLOOD, 15 NOVEMBER 2002 VOLUME 100, NUMBER Broughton BC, Steingrimsdottir H, Lehmann AR. Five polymorphisms in the coding sequence of the xeroderma pigmentosum group D gene. Mutat Res. 1996;15: Matullo G, Palli D, Peluso M, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis. 2001;22: Lunn RM, Helzlsouer KJ, Parshad R, et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis. 2000;21: Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics. 1995;5: Siegel D, McGuinness SM, Winski SL, Ross D. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. Pharmacogenetics. 1999;9: Smith MT, Wang Y, Kane E, et al. Low NAD(P)H: quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults. Blood. 2001;97: Larson RA, Wang Y, Banerjee M, et al. Prevalence of the inactivating 609C3T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood. 1999;94: Sturgis EM, Castillo EJ, Li L, et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis. 1999;20: Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999;59: Ben-Yehuda D, Krichevsky S, Caspi O, et al. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood. 1996;88: Zhu YM, Das-Gupta EP, Russell NH. Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia. Blood. 1999;94: Das-Gupta EP, Seedhouse CH, Russell NH. Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia. Br J Haematol. 2001;14: Duell EJ, Millikan RC, Pittman GS, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev. 2001;10: Divine KK, Gilliland FD, Crowell RE, et al. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat Res. 2001; 461: Duell EJ, Wiencke JK, Cheng TJ, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 2000;21: Abdel-Rahman SZ, El-Zein RA. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett. 2000;159: Abdel-Rahman SZ, Soliman AS, Bondy ML, et al. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett. 2000;159: Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10: Nelson HH, Kelsey KT, Mott LA, Karagas MR. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res. 2002; 62:
Original Article Association between XRCC1 and ERCC2 gene. polymorphisms and development of osteosarcoma.
Int J Clin Exp Pathol 2016;9(1):223-229 www.ijcep.com /ISSN:1936-2625/IJCEP0017837 Original Article Association between XRCC1 and ERCC2 gene polymorphisms and development of osteosarcoma Zimin Wang 1,
More informationXRCC3 T241M polymorphism and melanoma skin cancer risk: A meta-analysis
ONCOLOGY LETTERS 9: 2425-2429, 2015 XRCC3 T241M polymorphism and melanoma skin cancer risk: A meta-analysis JINGHUA FAN 1, YUHUA FAN 2, XIAOXIAO KANG 1 and LIMIN ZHAO 1 1 Department of Dermatology, Xi'an
More informationTHE ROLE OF XRCC1 POLYMORPHISMS IN BASE EXCISION REPAIR OF ETHENO-DNA ADDUCTS IN FRENCH VINYL CHLORIDE WORKERS
Nofer Institute of Occupational Medicine, Łódź, Poland OCCUPATIONAL PAPERS International Journal of Occupational Medicine and Environmental Health 2006;19(1):45 52 DOI 10.2478/v10001-006-0006-9 THE ROLE
More informationXRCC1 Polymorphisms and Cancer Risk: A Meta-analysis of 38 Case-Control Studies
1810 Cancer Epidemiology, Biomarkers & Prevention XRCC1 Polymorphisms and Cancer Risk: A Meta-analysis of 38 Case-Control Studies Zhibin Hu, 1 Hongxia Ma, 1 Feng Chen, 1 Qingyi Wei, 2 and Hongbing Shen
More informationXRCC1 Polymorphisms and Pancreatic Cancer: A Meta-Analysis
www.springerlink.com Chin J Cancer Res 23(3):165-170, 2011 165 Review Article XRCC1 Polymorphisms and Pancreatic Cancer: A Meta-Analysis Wei-dong Shen 1, Hong-lin Chen 2*, Peng-fei Liu 1 1 Department of
More informationAssociation between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population
Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population R. Zhao and M.F. Ying Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University,
More informationH.F. Liu, J.S. Liu, J.H. Deng and R.R. Wu. Corresponding author: J.S. Liu
Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics H.F. Liu, J.S. Liu, J.H. Deng and R.R. Wu Department
More informationInvestigation of the role of XRCC1 genetic polymorphisms in the development of gliomas in a Chinese population
Investigation of the role of XRCC1 genetic polymorphisms in the development of gliomas in a Chinese population S.C. Fan 1, J.G. Zhou 2 and J.Z. Yin 1 1 Department of Neurosurgery, The People s Hospital
More informationPolymorphism of XRCC1 Gene Exon 6 (Arg194Trp) in Relation to Micronucleus Frequencies in Hospital Radiation Workers
Atom Indonesia Vol. 44 No. 2 (218) 15-111 N. Adventini et al. / Atom Indonesia Vol. 43 No. xxx (217) xxx - xxx Atom Indonesia Journal homepage: http://aij.batan.go.id Polymorphism of XRCC1 Gene Exon 6
More informationXRCC3 Thr241Met Gene Polymorphism and Risk of Colorectal Cancer in Kashmir: a Case Control Study
RESEARCH ARTICLE XRCC3 Thr241Met Gene Polymorphism and Risk of Colorectal Cancer in Kashmir: a Case Control Study Saniya Nissar 1,4, Aga Syed Sameer 3, Tufail A Lone 2, Nissar A Chowdri 2, Roohi Rasool
More informationAssociation between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk
Association between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk B.B. Sun, J.Z. Wu, Y.G. Li and L.J. Ma Department of Respiratory Medicine, People s Hospital Affiliated to
More informationAssociation between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer
Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer M.G. He, K. Zheng, D. Tan and Z.X. Wang Department of Hepatobiliary Surgery, Nuclear Industry 215 Hospital
More informationReview Article Influence of XRCC1 Genetic Polymorphisms on Ionizing Radiation-Induced DNA Damage and Repair
SAGE-Hindawi Access to Research Journal of Nucleic Acids Volume 2010, Article ID 780369, 6 pages doi:10.4061/2010/780369 Review Article Influence of XRCC1 Genetic Polymorphisms on Ionizing Radiation-Induced
More informationInfluence of the c.1517g>c genetic variant in the XRCC1 gene on pancreatic cancer susceptibility in a Chinese population
Influence of the c.1517g>c genetic variant in the XRCC1 gene on pancreatic cancer susceptibility in a Chinese population Z.M. Zhao*, C.G. Li*, M.G. Hu, Y.X. Gao and R. Liu Department of Surgical Oncology,
More informationChapter 2 Susceptibility to MDS: DNA Repair and Detoxification Genes
Chapter 2 Susceptibility to MDS: DNA Repair and Detoxification Genes Claire Seedhouse and Nigel Russell Introduction The myelodysplastic syndromes (MDS) are a collection of heterogeneous disorders arising
More informationAssociation between ERCC1 and XPF polymorphisms and risk of colorectal cancer
Association between ERCC1 and XPF polymorphisms and risk of colorectal cancer H. Yang, G. Li and W.F. Li Departments of Radiation Oncology and Chemotherapy, The First Affiliated Hospital of Wenzhou Medical
More informationFrequency of XRCC1 Exon 9 G>A gene polymorphism in Saudi Arabian population: A comparative study with worldwide
JBUON 2018; 23(4): 1195-1199 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Frequency of XRCC1 Exon 9 G>A gene polymorphism in Saudi Arabian population:
More informationVariants in DNA Repair Genes and Glioblastoma. Roberta McKean-Cowdin, PhD
Variants in DNA Repair Genes and Glioblastoma Advances in Bioinformatics and Genomics Symposium February 19, 2010 Roberta McKean-Cowdin, PhD Department of Preventive Medicine, University of Southern California
More informationResearch Article An Association between Single Nucleotide Polymorphisms of Lys751Gln ERCC2 Gene and Ovarian Cancer in Polish Women
Advances in Medicine Volume 2015, Article ID 109593, 6 pages http://dx.doi.org/10.1155/2015/109593 Research Article An Association between Single Nucleotide Polymorphisms of Lys751Gln ERCC2 Gene and Ovarian
More informationPolymorphisms in DNA Repair Gene XRCC1 and Skin Cancer Risk: A Meta-analysis
Polymorphisms in DNA Repair Gene XRCC1 and Skin Cancer Risk: A Meta-analysis HAIJUN ZHANG 1, WENJUAN LI 2, MICHAEL J. FRANKLIN 3 and ARKADIUSZ Z. DUDEK 3 1 Department of Cell and Developmental Biology,
More informationXRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia
XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia J.P. Meza-Espinoza 1, V. Peralta-Leal 1, M. Gutierrez-Angulo 2, N. Macias-Gomez 3, M.L. Ayala-Madrigal 4, P. Barros-Nuñez
More informationCorresponding author: M.S. Monteiro
Association among XRCC1, XRCC3, and BLHX gene polymorphisms and chromosome instability in lymphocytes from patients with endometriosis and ovarian cancer M.S. Monteiro 1, D.B. Vilas Boas 2, C.B. Gigliotti
More informationGenetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma
Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma M.J. Wang, Y. Zhu, X.J. Guo and Z.Z. Tian Department of Orthopaedics, Xinxiang Central Hospital, Xinxiang,
More informationPolymorphisms of XPC Gene And Susceptibility of Esophageal Cancer
www.springerlink.co Chin J Cancer Res 22(1):49-54, 2010 49 Original Article Polymorphisms of XPC Gene And Susceptibility of Esophageal Cancer Xiang-xian Feng 1, 2, Pei-fen Duan 2, Li-bing Wang 2, Zu-xun
More informationDepartment of Respiratory Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China
Association of glutathione S-transferase (GST) genetic polymorphisms with treatment outcome of cisplatin-based chemotherapy for advanced non-small cell lung cancer in a Chinese population H.L. Xiao 1,
More informationIntroduction to Genetics
Introduction to Genetics Table of contents Chromosome DNA Protein synthesis Mutation Genetic disorder Relationship between genes and cancer Genetic testing Technical concern 2 All living organisms consist
More informationMyoglobin A79G polymorphism association with exercise-induced skeletal muscle damage
Myoglobin A79G polymorphism association with exercise-induced skeletal muscle damage T. Cui and M.S. Jiang College of Physical Education, Shandong University of Finance and Economics, Ji nan, Shandong,
More informationPolymorphisms of DNA repair-related genes with susceptibility and prognosis of prostate cancer
Polymorphisms of DNA repair-related genes with susceptibility and prognosis of prostate cancer X.J. Zhang, P. Liu and F. Zhu Urology Department, The First Affiliated Hospital of Xinxiang Medical University,
More informationBiochemistry 201: DNA repair January 24, 26, 2000 Gilbert Chu
1) Why study DNA repair? Biochemistry 201: DNA repair January 24, 26, 2000 Gilbert Chu The genome is assaulted by a myriad of different agents that cause DNA damage. Sources of damage can be both exogenous
More informationNIH Public Access Author Manuscript Am J Gastroenterol. Author manuscript; available in PMC 2008 March 17.
NIH Public Access Author Manuscript Published in final edited form as: Am J Gastroenterol. 2008 February ; 103(2): 360 367. XRCC2 and XRCC3 Gene Polymorphism and Risk of Pancreatic Cancer Li Jiao, Ph.D.
More informationGenetic variation in XRCC1, sun exposure, and risk of skin cancer
British Journal of Cancer (2004) 91, 1604 1609 All rights reserved 0007 0920/04 $30.00 www.bjcancer.com J Han*,1,2, SE Hankinson 1,3, GA Colditz 1,3 and DJ Hunter 1,2,3 1 Channing Laboratory, Department
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Genetic Polymorphism of DNA Repair Genes (, XRCC2 & XRCC3) in Breast Kailas D. Datkhile 1,
More informationORIGINAL ARTICLE. DNA Repair Gene ERCC1 and ERCC2/XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck
ORIGINAL ARTICLE DNA Repair Gene ERCC1 and ERCC2/XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck Erich M. Sturgis, MD; Kristina R. Dahlstrom, BS; Margaret R. Spitz, MD, MPH;
More informationLESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2
For a complete list of defined terms, see the Glossary. Transformation the process by which a cell acquires characteristics of a tumor cell. LESSON 3.2 WORKBOOK How do normal cells become cancer cells?
More informationCancer. Questions about cancer. What is cancer? What causes unregulated cell growth? What regulates cell growth? What causes DNA damage?
Questions about cancer What is cancer? Cancer Gil McVean, Department of Statistics, Oxford What causes unregulated cell growth? What regulates cell growth? What causes DNA damage? What are the steps in
More informationAmerican Journal of EPIDEMIOLOGY
Volume 161 Number 1 January 1, 2005 American Journal of EPIDEMIOLOGY Copyright 2005 by The Johns Hopkins Bloomberg School of Public Health Sponsored by the Society for Epidemiologic Research Published
More informationAward Number: W81XWH TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer
AD Award Number: W81XWH-04-1-0579 TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer PRINCIPAL INVESTIGATOR: Yuichiro Tanaka, Ph.D. Rajvir Dahiya, Ph.D. CONTRACTING ORGANIZATION:
More informationAssociation of polymorphisms of the xeroderma pigmentosum complementation group F gene with increased glioma risk
Association of polymorphisms of the xeroderma pigmentosum complementation group F gene with increased glioma risk W.K. Zhou 1, L.Y. Huang 1, L. Hui 1, Z.W. Wang 1, B.Z. Jin 1, X.L. Zhao 1, X.Z. Zhang 1,
More informationAssociation of DNA Double strand Break Gene XRCC6 Genotypes and Lung Cancer in Taiwan
Association of DNA Double strand Break Gene XRCC6 Genotypes and Lung Cancer in Taiwan TE-CHUN HSIA 1,2,4, CHIN-JUNG LIU 1,3, CHIA-CHEN CHU 1,3, LIANG-WEN HANG 1,3, WEN-SHIN CHANG 1,5, CHIA-WEN TSAI 1,5,
More informationSALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407
SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407 The Mismatch Repair (MMR) system is critical for the maintenance of genomic stability. MMR increases the fidelity of DNA
More informationMousumi Majumder, 1 Nilabja Sikdar, 1 Ranjan Rashmi Paul, 2 and Bidyut Roy 1. Abstract. Introduction
2106 Increased Risk of Oral Leukoplakia and Cancer Among Mixed Tobacco Users Carrying XRCC1 Variant Haplotypes and Cancer Among Smokers Carrying Two Risk Genotypes: One on Each of Two Loci, GSTM3 and XRCC1
More informationXRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients
Li et al. Radiation Oncology 2013, 8:31 RESEARCH Open Access XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients
More informationDNA repair gene XRCC1 Arg194Trp polymorphism and susceptibility to hepatocellular carcinoma: A meta analysis
ONCOLOGY LETTERS 8: 1725-1730, 2014 DNA repair gene XRCC1 Arg194Trp polymorphism and susceptibility to hepatocellular carcinoma: A meta analysis WENYAN LI 1, FENG YANG 2, YONGXIAN GUI 1 and JUNJIE BIAN
More informationGenetic polymorphisms and head and neck cancer risk (Review)
INTERNATINAL JURNAL F NCLGY 32: 945-973, 2008 945 Genetic polymorphisms and head and neck cancer risk (Review) TRU HIYAMA 1, MASAHARU YSHIHARA 1, SHINJI TANAKA 2 and KAZUAKI CHAYAMA 3 1 Health Service
More informationAsingle inherited mutant gene may be enough to
396 Cancer Inheritance STEVEN A. FRANK Asingle inherited mutant gene may be enough to cause a very high cancer risk. Single-mutation cases have provided much insight into the genetic basis of carcinogenesis,
More informationDNA repair gene XRCC3 T241M polymorphism and susceptibility to hepatocellular carcinoma in a Chinese population: a meta-analysis
DNA repair gene XRCC3 T241M polymorphism and susceptibility to hepatocellular carcinoma in a Chinese population: a meta-analysis R.B. Ji, Y.S. Qian, A.R. Hu and Y.R. Hu Liver Disease Research Center, Ningbo
More informationPolymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women
www.bioinformation.net Volume 13(5) Hypothesis Polymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women Maniraja Jesintha
More informationOriginal Article The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk in a Chinese Han population
Int J Clin Exp Med 2014;7(12):5832-5836 www.ijcem.com /ISSN:1940-5901/IJCEM0002117 Original Article The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk
More informationNew: P077 BRCA2. This new probemix can be used to confirm results obtained with P045 BRCA2 probemix.
SALSA MLPA KIT P045-B2 BRCA2/CHEK2 Lot 0410, 0609. As compared to version B1, four reference probes have been replaced and extra control fragments at 100 and 105 nt (X/Y specific) have been included. New:
More informationDistribution of Polymorphisms in DNA Repair Genes (RAD51 and XRCC3) in Cases of De Novo Acute Myeloid Leukaemia
Journal of Molecular Diagnosis and Vaccines Vol. 6, 2008 Page: 1-9 Distribution of Polymorphisms in DNA Repair Genes (RAD51 and XRCC3) in Cases of De Novo Acute Myeloid Leukaemia 1* Amani Sorour, 2 Dalia
More informationInvestigation on the role of XPG gene polymorphisms in breast cancer risk in a Chinese population
Investigation on the role of XPG gene polymorphisms in breast cancer risk in a Chinese population S.H. Ma 1,2, F.H. Ling 2, Y.X. Sun 3, S.F. Chen 2 and Z. Li 1 1 Department of General Surgery, Zhujiang
More informationInvestigating the role of polymorphisms in mir-146a, -149, and -196a2 in the development of gastric cancer
Investigating the role of polymorphisms in mir-146a, -149, and -196a2 in the development of gastric cancer Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong
More informationSignificant Association of Ku80 Single Nucleotide Polymorphisms with Bladder Cancer Susceptibility in Taiwan
Significant Association of Ku80 Single Nucleotide Polymorphisms with Bladder Cancer Susceptibility in Taiwan CHAO-HSIANG CHANG 1,2*, CHANG-FANG CHIU 2,3*, SHIU-YUN LIANG 2*, HSI-CHIN WU 1,2, CHIA-LIN CHANG
More informationXRCC1 gene polymorphisms in a population sample and in women with a family history of breast cancer from Rio de Janeiro (Brazil)
Short Communication Genetics and Molecular Biology, 32, 2, 255-259 (2009) Copyright 2009, Sociedade Brasileira de Genética. Printed in Brazil www.sbg.org.br XRCC1 gene polymorphisms in a population sample
More informationPolymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer
PO Box 2345, Beijing 100023, China World J Gastroenterol 2005;11(42):6593-6600 www.wjgnet.com World Journal of Gastroenterology ISSN 1007-9327 wjg@wjgnet.com ELSEVIER 2005 The WJG Press and Elsevier Inc.
More informationTITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer
AD Award Number: W81XWH-04-1-0579 TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer PRINCIPAL INVESTIGATOR: Yuichiro Tanaka, Ph.D. CONTRACTING ORGANIZATION: Northern California
More informationMUTATIONS, MUTAGENESIS, AND CARCINOGENESIS. (Start your clickers)
MUTATIONS, MUTAGENESIS, AND CARCINOGENESIS (Start your clickers) How do mutations arise? And how do they affect a cell and its organism? Mutations: heritable changes in genes Mutations occur in DNA But
More informationRole of Paired Box9 (PAX9) (rs ) and Muscle Segment Homeobox1 (MSX1) (581C>T) Gene Polymorphisms in Tooth Agenesis
EC Dental Science Special Issue - 2017 Role of Paired Box9 (PAX9) (rs2073245) and Muscle Segment Homeobox1 (MSX1) (581C>T) Gene Polymorphisms in Tooth Agenesis Research Article Dr. Sonam Sethi 1, Dr. Anmol
More informationMRC-Holland MLPA. Description version 29;
SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,
More informationThis exam consists of two parts. Part I is multiple choice. Each of these 25 questions is worth 2 points.
MBB 407/511 Molecular Biology and Biochemistry First Examination - October 1, 2002 Name Social Security Number This exam consists of two parts. Part I is multiple choice. Each of these 25 questions is
More informationLack of association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population
Lack of association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population J.J. Lu, H.Q. Zhang, P. Mai, X. Ma, X. Chen, Y.X. Yang and L.P. Zhang Gansu Provincial Hospital, Donggang
More informationTable S1. Primers and PCR protocols for mutation screening of MN1, NF2, KREMEN1 and ZNRF3.
Table S1. Primers and PCR protocols for mutation screening of MN1, NF2, KREMEN1 and ZNRF3. MN1 (Accession No. NM_002430) MN1-1514F 5 -GGCTGTCATGCCCTATTGAT Exon 1 MN1-1882R 5 -CTGGTGGGGATGATGACTTC Exon
More informationAssociation of XRCC1 gene polymorphisms and pancreatic cancer risk in a Chinese population
Association of XRCC1 gene polymorphisms and pancreatic cancer risk in a Chinese population L.J. Wang 1, H.T. Wang 1 and X.X. Wang 2 1 Department of Hepatobiliary Surgery, Yantai Affiliated Hospital of
More informationAssociation between rs G<C gene polymorphism and susceptibility to pancreatic cancer in a Chinese population
Association between rs9904341 G
More informationAllelic and Haplotype Frequencies of the p53 Polymorphisms in Brain Tumor Patients
Physiol. Res. 51: 59-64, 2002 Allelic and Haplotype Frequencies of the p53 Polymorphisms in Brain Tumor Patients E. BIROŠ, I. KALINA, A. KOHÚT 1, E. BOGYIOVÁ 2, J. ŠALAGOVIČ, I. ŠULLA 3 Department of Medical
More informationSupplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our
1 2 Supplemental Data: Detailed Characteristics of Patients with MKRN3 Mutations 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Patient 1 was born after an uneventful pregnancy. She presented
More informationCYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women
CYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women L. Yang, X.Y. Wang, Y.T. Li, H.L. Wang, T. Wu, B. Wang, Q. Zhao, D. Jinsihan and L.P. Zhu The Department of Mammary
More informationMRC-Holland MLPA. Description version 06; 23 December 2016
SALSA MLPA probemix P417-B2 BAP1 Lot B2-1216. As compared to version B1 (lot B1-0215), two reference probes have been added and two target probes have a minor change in length. The BAP1 (BRCA1 associated
More informationBrian T Burgess, DO, PhD, GYN Oncology Fellow Rachel W. Miller, MD, GYN Oncology
Brian T Burgess, DO, PhD, GYN Oncology Fellow Rachel W. Miller, MD, GYN Oncology Epithelial Ovarian Cancer - Standard Current Treatment: Surgery with De-bulking + Platinum-Taxane based Chemotherapy - No
More informationTumor suppressor genes D R. S H O S S E I N I - A S L
Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to
More informationAdditions to the Medical Geologist s Toolbox
Additions to the Medical Geologist s Toolbox Application of Sensitive Biological Endpoints to Assess Human Exposure and Potential Health Effects at Low Environmental Contaminant Concentrations Malcolm
More informationG20210A prothrombin gene mutation identified in patients with venous leg ulcers
J.Cell.Mol.Med. Vol 5, No 4, 2001 pp. 397-401 G20210A prothrombin gene mutation identified in patients with venous leg ulcers Gh. Jebeleanu, Lucia Procopciuc * Department of Medical Biochemistry, University
More informationInhibidores de PARP Una realidad? dónde y cuando?
Inhibidores de PARP Una realidad? dónde y cuando? Alberto Ocana Hospital Universitario Albacete Centro Regional Investigaciones Biomédicas CIC-Salamanca DNA repair mechanisms DNA is continually exposed
More informationInfluence of ERCC2 gene polymorphisms on the treatment outcome of osteosarcoma
Influence of ERCC2 gene polymorphisms on the treatment outcome of osteosarcoma Z.F. Liu, A.L.J. Asila, K. Aikenmu, J. Zhao, Q.C. Meng and R. Fang Department of Orthopaedics, Chinese Medicine Hospital of
More informationChapter 9. Cells Grow and Reproduce
Chapter 9 Cells Grow and Reproduce DNA Replication DNA polymerase Addition of a nucleotide to the 3 end of a growing strand Use dntps as substrate Release of pyrophosphate Initiation of Replication Replication
More informationAssociation between IL-17A and IL-17F gene polymorphisms and risk of gastric cancer in a Chinese population
Association between IL-17A and IL-17F gene polymorphisms and risk of gastric cancer in a Chinese population W.M. Zhao 1, P. Shayimu 1, L. Liu 1, F. Fang 1 and X.L. Huang 2 1 Department of Gastrointestinal
More informationDifferentiation-induced Changes of Mediterranean Fever Gene (MEFV) Expression in HL-60 Cell
Differentiation-induced Changes of Mediterranean Fever Gene (MEFV) Expression in HL-60 Cell Wenxin Li Department of Biological Sciences Fordham University Abstract MEFV is a human gene that codes for an
More informationInvestigation on ERCC5 genetic polymorphisms and the development of gastric cancer in a Chinese population
Investigation on ERCC5 genetic polymorphisms and the development of gastric cancer in a Chinese population L.Q. Yang 1, Y. Zhang 2 and H.F. Sun 3 1 Department of Gastroenterology, The Second Affiliated
More informationInherited Cancer Syndromes and the DNA Damage Response
Inherited Cancer Syndromes and the DNA Damage Response Inherited Breast Cancer and DNA Double- Strand Break Repair Michal Goldberg Department of GeneGcs The Hebrew University Cancer Hub, March 2014 Hallmarks
More informationRESEARCH ARTICLE. Comprehensive Assessment of Associations between ERCC2 Lys751Gln/Asp312Asn Polymorphisms and Risk of Non- Hodgkin Lymphoma
RESEARCH ARTICLE Comprehensive Assessment of Associations between ERCC2 Lys751Gln/Asp312Asn Polymorphisms and Risk of Non- Hodgkin Lymphoma Jue-Yu Zhou 1& *, Li-Wen He 1,2&, Jie Liu 3, Hai-Lang Yu 1, Min
More informationXRCC3 THR241MET POLYMORPHISM IS NOT ASSOCIATED WITH LUNG CANCER RISK IN A ROMANIAN POPULATION
DOI: 10.15386/cjmed-523 XRCC3 THR241MET POLYMORPHISM IS NOT ASSOCIATED WITH LUNG CANCER RISK IN A ROMANIAN POPULATION ANDREEA CATANA 1, MONICA POP 2, DRAGOS HOREA MARGINEAN 1, IOANA CRISTINA BLAGA 1, MIHAI
More informationVariations in Chromosome Structure & Function. Ch. 8
Variations in Chromosome Structure & Function Ch. 8 1 INTRODUCTION! Genetic variation refers to differences between members of the same species or those of different species Allelic variations are due
More informationLung cancer remains the deadliest cancer worldwide despite
ORIGINAL ARTICLE ERCC2/XPD Lys751Gln and Asp312Asn Gene Polymorphism and Lung Cancer Risk A Meta-Analysis Involving 22 Case Control Studies Ping Zhan, MD,* Qin Wang, MD, Shu-Zhen Wei, MD, Jing Wang, MD,
More informationObjective: You will be able to explain how the subcomponents of
Objective: You will be able to explain how the subcomponents of nucleic acids determine the properties of that polymer. Do Now: Read the first two paragraphs from enduring understanding 4.A Essential knowledge:
More informationoncogenes-and- tumour-suppressor-genes)
Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging
More informationMLH1 and XRCC1 polymorphisms in Mexican patients with colorectal cancer
MLH1 and XRCC1 polymorphisms in Mexican patients with colorectal cancer R. Muñiz-Mendoza 1, M.L. Ayala-Madrigal 1, M. Partida-Pérez 1, J. Peregrina-Sandoval 2, E. Leal-Ugarte 3, N. Macías-Gómez 4, V. Peralta-Leal
More informationAberrant DNA methylation of MGMT and hmlh1 genes in prediction of gastric cancer
Aberrant DNA methylation of MGMT and hmlh1 genes in prediction of gastric cancer J. Jin 1,2, L. Xie 2, C.H. Xie 1 and Y.F. Zhou 1 1 Department of Radiation & Medical Oncology, Zhongnan Hospital of Wuhan
More informationVirtual Journal Club. Ovarian Cancer. Reference Slides. Platinum-Sensitive Recurrent Ovarian Cancer: Making the Most of Emerging Targeted Therapies
Virtual Journal Club Ovarian Cancer Reference Slides Platinum-Sensitive Recurrent Ovarian Cancer: Making the Most of Emerging Targeted Therapies Mansoor R. Mirza, MD Copenhagen University Hospital Rigshospitalet
More informationInferring causality in observational epidemiology: Breast Cancer Risk as an Example
Inferring causality in observational epidemiology: Breast Cancer Risk as an Example Mary Beth Terry, PhD Department of Epidemiology and Environmental Sciences Cancer Genes vs Environmental Risk Factors
More informationApplication of chromosomal radiosensitivity assays to temporary nuclear power plant workers
Application of chromosomal radiosensitivity assays to temporary nuclear power plant workers Research group University Ghent in collaboration with Dr. M. Barbé and the Occupational Medicine Service Nuclear
More informationIdentification and characterization of multiple splice variants of Cdc2-like kinase 4 (Clk4)
Identification and characterization of multiple splice variants of Cdc2-like kinase 4 (Clk4) Vahagn Stepanyan Department of Biological Sciences, Fordham University Abstract: Alternative splicing is an
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationDiversity and Frequencies of HLA Class I and Class II Genes of an East African Population
Open Journal of Genetics, 2014, 4, 99-124 Published Online April 2014 in SciRes. http://www.scirp.org/journal/ojgen http://dx.doi.org/10.4236/ojgen.2014.42013 Diversity and Frequencies of HLA Class I and
More informationMultistep Carcinogenesis
Multistep Carcinogenesis M.Rosemann, Institute for Radiation Biology Helmholtz Center Munich, Research Centre for Health and Environment The Hallmarks of Cancer D.Hanahan, Cell 2011 The Hallmarks of Cancer
More informationAssociation between MTHFR 677C/T and 1298A/C gene polymorphisms and breast cancer risk
Association between MTHFR 677C/T and 1298A/C gene polymorphisms and breast cancer risk X.F. Zhang 1, T. Liu 2, Y. Li 1 and S. Li 2 1 Department of Breast, Liao Ning Cancer Hospital and Institute, Shenyang,
More informationSmoke Like a Man, Survive Like a Woman
Smoke Like a Man, Survive Like a Woman Sex Specific Differences in Lung Cancer Pulmonary Grand Rounds Philippe R. Montgrain, M.D. May 1, 2008 Objectives 1. Review how lung cancer differs in men and women.
More informationHST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007
MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.
More informationChemical Nature of the Amino Acids. Table of a-amino Acids Found in Proteins
Chemical Nature of the Amino Acids All peptides and polypeptides are polymers of alpha-amino acids. There are 20 a- amino acids that are relevant to the make-up of mammalian proteins (see below). Several
More informationCorporate Medical Policy. Policy Effective February 23, 2018
Corporate Medical Policy Genetic Testing for FLT3, NPM1 and CEBPA Mutations in Acute File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_flt3_npm1_and_cebpa_mutations_in_acute_myeloid_leukemia
More informationiplex genotyping IDH1 and IDH2 assays utilized the following primer sets (forward and reverse primers along with extension primers).
Supplementary Materials Supplementary Methods iplex genotyping IDH1 and IDH2 assays utilized the following primer sets (forward and reverse primers along with extension primers). IDH1 R132H and R132L Forward:
More information